Sagimet Biosciences Inc. logo SGMT - Sagimet Biosciences Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 6
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $8.00 DETAILS
HIGH: $8.00
LOW: $8.00
MEDIAN: $8.00
CONSENSUS: $8.00
UPSIDE: 24.42%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 0 0 2 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0.1
Gross Profit 0 0 2 0 0 0 (0.1)
Operating Expenses
R&D Expenses 39.1 38.4 19.8 24.9 19.3 8.2 8.4
SG&A Expenses 17.8 16.0 13.0 6.1 4.4 3.2 5.7
Other Expenses 0 0 0 0 0 0 0
Operating Expenses 56.9 54.5 32.7 31.1 23.7 11.4 14.1
Operating Income
Operating Income (56.9) (54.5) (30.7) (31.1) (23.7) (11.4) (14.2)
Interest Expense 0 0 0 0 0 0 0.1
Interest Income 0 0 2.9 0.6 0.0 0.0 0.1
Profitability
EBITDA (51.0) (45.6) (30.7) (31.1) (23.7) (11.4) (14.1)
EBIT (51.0) (45.6) (30.7) (31.1) (23.7) (11.4) (14.2)
Income Before Tax (51.0) (45.6) (27.9) (30.5) (24.4) (11.4) (14.3)
Income Tax Expense 0 0 0 0 0 0 0
Net Income (51.0) (45.6) (27.9) (30.5) (24.4) (11.4) (14.3)
Per Share Data
EPS (Basic) -1.58 -1.45 -1.53 -1.38 -1.10 -0.51 -0.64
EPS (Diluted) -1.58 -1.45 -1.53 -1.38 -1.10 -0.51 -0.64
Shares Outstanding 32.3 31.4 18.2 22.2 22.2 22.2 22.2
Metric 2025 2024 2023 2022 2021 2020 2019
Current Assets
Cash & Cash Equivalents 35.0 75.8 75.1 0.2 56.7 68.7 10.2
Short-Term Investments 78.1 75.4 19.8 32.2 0 0 0
Net Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 3.3 0.5 0.4 0.0 1.5 0.0 0.1
Total Current Assets 116.4 152.8 96.6 32.8 58.7 68.7 10.8
Non-Current Assets
Property, Plant & Equipment 0.1 0.1 0.1 0.2 0.3 0.2 0.3
Goodwill 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Long-Term Investments 0 7.4 0 0 0 0 0
Other Non-Current Assets 0 0 0 0.0 0.0 0.0 0.0
Total Non-Current Assets 0.1 7.5 0.1 0.2 0.4 0.2 0.3
Total Assets 116.5 160.3 96.7 33.0 59.0 69.0 11.2
Current Liabilities
Account Payables 1.3 1.4 0.2 1.1 0.8 0.5 1.2
Short-Term Debt 0.1 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0
Other Current Liabilities 3.7 0.0 0.6 0.1 0.2 0.2 0
Total Current Liabilities 5.1 4.5 5.7 5.3 2.4 1.9 2.1
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 214.6 214.6 202.9 134.2
Total Non-Current Liabilities 0 0 0 214.7 214.9 203.0 134.4
Total Liabilities 5.1 4.5 5.7 220.0 217.3 204.9 136.5
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (346.3) (295.3) (249.7) (221.9) (191.4) (166.9) (155.6)
Accumulated Other Comprehensive Income 0.1 0.2 0.0 (0.1) 0 0 0
Total Stockholders' Equity 111.4 155.8 91.1 (186.9) (158.3) (135.9) (125.3)
Total Liabilities & Equity 116.5 160.3 96.7 33.0 59.0 69.0 11.2
Debt Metrics
Total Debt 0.1 0.1 0.1 0.2 0.3 0.2 0.3
Net Debt (34.9) (75.8) (75.1) 0.1 (56.4) (68.5) (9.9)
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income (51.0) (45.6) (27.9) (30.5) (24.4) (11.4) (14.3)
Depreciation & Amortization 0 0 0 0.1 0 0 0.0
Stock-Based Compensation 6.4 5.3 5.0 1.9 1.9 0.8 3.0
Change in Working Capital (1.1) (1.0) (1.0) 4.2 (0.1) 0.1 0.6
Other Non-Cash Items (0.0) (1.1) 0.1 (0.2) 0.9 0.1 0.1
Operating Cash Flow (45.6) (42.4) (23.8) (24.5) (21.7) (10.4) (10.6)
Investing Activities
Capital Expenditure 0 0 0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0
Purchases of Investments (106.9) (108.1) (19.6) (41.4) 0 0 0
Sales/Maturities of Investments 111.4 46.4 32.2 9.4 0 0 0
Other Investing Activities 0 0 0 0 0 0.0 (0.0)
Investing Cash Flow 4.6 (61.7) 12.6 (32.0) 0 0.0 (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 (3.4)
Stock Repurchased 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 0 (0.9) (3.5) (0.1) (1.1) 0 0
Financing Cash Flow 0.3 104.8 86.2 (0.1) 9.7 68.9 18.5
Cash Position
Net Change in Cash (40.8) 0.7 75.0 (56.6) (12.0) 58.5 7.9
Cash at Beginning 75.8 75.1 0.2 56.7 68.7 10.2 2.3
Cash at End 35.0 75.8 75.1 0.2 56.7 68.7 10.2
Free Cash Flow (45.6) (42.4) (23.8) (24.5) (21.7) (10.4) (10.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 0 0 2 0 0 0 0
Gross Profit 0 0 2 0 0 0 (0.1)
Operating Income (56.9) (54.5) (30.7) (31.1) (23.7) (11.4) (14.2)
Net Income (51.0) (45.6) (27.9) (30.5) (24.4) (11.4) (14.3)
EPS (Diluted) -1.58 -1.45 -1.53 -1.38 -1.10 -0.51 -0.64
Balance Sheet
Cash & Equivalents 35.0 75.8 75.1 0.2 56.7 68.7 10.2
Total Assets 116.5 160.3 96.7 33.0 59.0 69.0 11.2
Total Debt 0.1 0.1 0.1 0.2 0.3 0.2 0.3
Stockholders' Equity 111.4 155.8 91.1 (186.9) (158.3) (135.9) (125.3)
Cash Flow
Operating Cash Flow (45.6) (42.4) (23.8) (24.5) (21.7) (10.4) (10.6)
Capital Expenditure 0 0 0 0 0 0 0
Free Cash Flow (45.6) (42.4) (23.8) (24.5) (21.7) (10.4) (10.6)